Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies (Aspire)

January 20, 2016 updated by: United Therapeutics

A Postmarketing Observational Study to Assess Respiratory Tract Adverse Events in Pulmonary Arterial Hypertension Patients Treated With Tyvaso® (Treprostinil) Inhalation Solution

A surveillance of respiratory tract related adverse events in patients treated with Tyvaso®(treprostinil) Inhalation Solution versus other FDA approved therapies

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A post marketing surveillance to determine the type and incidence of oro/nasopharyngeal or pulmonary adverse events that may occur in patients treated with commercially available Tyvaso®(treprostinil) Inhalation Solution. A comparison will be made to the type and incidence of events in patients receiving other FDA approved therapies for pulmonary arterial hypertension, as a control measure.

Study Type

Observational

Enrollment (Actual)

1333

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Alabama
      • Birmingham, Alabama, United States, 35294
        • The University of Alabama at Birmingham
      • Birmingham, Alabama, United States, 35213
        • Cardiovascular Associates, P.C.
      • Mobile, Alabama, United States, 36693
        • University of South Alabama
    • Arizona
      • Phoenix, Arizona, United States, 85013
        • Arizona Pulmonary Specialists, Ltd
    • California
      • Berkeley, California, United States, 94705
        • Berkeley Cardiovascular Medical Group
      • Beverly Hills, California, United States, 90211
        • Cedars-Sinai Heart Institute
      • Fresno, California, United States, 93721
        • University California San Francisco
      • Los Angeles, California, United States, 90033
        • University of Southern California
      • Los Angeles, California, United States, 90073
        • West Los Angeles VA Healthcare Center
      • Sacramento, California, United States, 95817
        • University of California Davis Medical Center
      • San Francisco, California, United States, 94143
        • University of California, San Francisco
      • San Juan Capistrano, California, United States, 92675
        • Paloma Medical Group
      • Santa Barbara, California, United States, 93105
        • Santa Barbara Cottage Hospital
      • Stanford, California, United States, 94305
        • Stanford Hospital and Clinics
    • Colorado
      • Denver, Colorado, United States, 80045
        • Children's Hospital Denver
      • Wheat Ridge, Colorado, United States, 80033
        • Western States Clinical Research, Inc.
    • Florida
      • Clearwater, Florida, United States, 33765
        • St. Francis Sleep Allergy & Lung
      • Gainesville, Florida, United States, 32610
        • University of Florida
      • Jacksonville, Florida, United States, 32224
        • Mayo Clinic Jacksonville
      • Jacksonville, Florida, United States, 32209
        • University of Florida College of Medicine Jacksonville
      • Jacksonville, Florida, United States, 32204
        • Pulmonary and Critical Care Associates
      • Miami, Florida, United States, 33136
        • Miami Center for Cardiovascular Disease
      • Miami Beach, Florida, United States, 33140
        • Mount Sinai Medical Center
      • Orlando, Florida, United States, 32806
        • Orlando Heart Center
      • Orlando, Florida, United States, 32806
        • Central Florida Pulmonary Group, P.A.
      • Weston, Florida, United States, 33331
        • Cleveland Clinic Florida
    • Georgia
      • Atlanta, Georgia, United States, 30322
        • Emory University School of Medicine
      • Austell, Georgia, United States, 30106
        • Georgia Lung Associates, PC
    • Illinois
      • Chicago, Illinois, United States, 60612
        • University of Illinois at Chicago
      • Chicago, Illinois, United States, 60612
        • Rush University Medical Center
      • Chicago, Illinois, United States, 60611
        • Northwestern Medical Center
      • Oakbrook Terrace, Illinois, United States, 60181
        • Midwest Heart Foundation
    • Indiana
      • Carmel, Indiana, United States, 46032
        • Indiana University Hospital
    • Iowa
      • Iowa City, Iowa, United States, 52242
        • University of Iowa
      • Iowa City, Iowa, United States, 52245
        • Mercy Hospital
    • Kansas
      • Kansas City, Kansas, United States, 66160
        • University of Kansas Medical Center
    • Kentucky
      • Louisville, Kentucky, United States, 40202
        • Kentuckiana Pulmonary Associates
    • Maryland
      • Baltimore, Maryland, United States, 21201
        • University of Maryland
      • Baltimore, Maryland, United States, 21205
        • Johns Hopkins University
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Brigham and Women's Hospital
      • Boston, Massachusetts, United States, 02111
        • TUFTS - New England Medical Center
    • Michigan
      • Detroit, Michigan, United States, 48202
        • Henry Ford Health System
      • Troy, Michigan, United States, 48085
        • William Beaumont Hospital
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic
    • Nebraska
      • Lincoln, Nebraska, United States, 68506
        • Nebraska Pulmonary Specialties, LLC
    • New Jersey
      • Hackensack, New Jersey, United States, 07601
        • Hackensack University Medical Center
      • New Brunswick, New Jersey, United States, 08903
        • UMDNJ - Robert Wood Johnson Medical Center Clinical Research Center
      • Newark, New Jersey, United States, 07112
        • Newark Beth Israel Medical Center
    • New York
      • Islandia, New York, United States, 11790
        • SUNY Stony Brook University Medical Center
      • Mineola, New York, United States, 11501
        • Winthrop Pulmonary Associates
      • New Hyde Park, New York, United States, 11040
        • North Shore - Long Island Jewish Health System
      • New York, New York, United States, 10032
        • Columbia University Medical Center
      • New York, New York, United States, 10019
        • St. Luke's-Roosevelt Hospital Center
      • Rochester, New York, United States, 14623
        • Mary M Parkes Center
      • Syracuse, New York, United States, 13210
        • Pulmonary Health Physicians
    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • University of North Carolina at Chapel Hill
      • Pinehurst, North Carolina, United States, 28374
        • Pinehurst Medical Clinic
      • Winston-Salem, North Carolina, United States, 27157
        • Wake Forest University Health Sciences
    • Ohio
      • Akron, Ohio, United States, 44302
        • Akron General Hospital
      • Cincinnati, Ohio, United States, 45267-0564
        • University of Cincinnati
      • Cleveland, Ohio, United States, 44106
        • University Hospitals Of Cleveland
      • Columbus, Ohio, United States, 43210
        • Davis Heart and Lung Research Institute
      • Fairfield, Ohio, United States, 45014
        • Mercy Fairfield Hospital
    • Oregon
      • Portland, Oregon, United States, 97210
        • Legacy Pulmonary Northwest
      • Portland, Oregon, United States, 97220
        • Oregon Clinic, PC
      • Portland, Oregon, United States, 97239
        • OHSU-Oregon Health and Science University
    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Penn State Milton S. Hershey Medical Center
      • Philadelphia, Pennsylvania, United States, 19104
        • Children's Hospital of Philadelphia
      • Philadelphia, Pennsylvania, United States, 19107
        • Thomas Jefferson University
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania Health System
      • Philadelphia, Pennsylvania, United States, 19140
        • Temple University
      • Pittsburgh, Pennsylvania, United States, 15212
        • Allegheny General Hospital
      • Pittsburgh, Pennsylvania, United States, 15213-2582
        • University of Pittsburgh Medical Center
      • Wyomissing, Pennsylvania, United States, 19610
        • Berks Schuylkill Respiratory Specialists, Ltd.
    • Rhode Island
      • Providence, Rhode Island, United States, 02903
        • Rhode Island Hospital
    • South Carolina
      • Lexington, South Carolina, United States, 29072
        • Lexington Pulmonary and Critical Care
    • Tennessee
      • Chattanooga, Tennessee, United States, 37419
        • MD Total Care, PLLC
      • Knoxville, Tennessee, United States, 37909
        • Summit Medical Group
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Medical Center
    • Texas
      • Dallas, Texas, United States, 75390
        • UT Southwestern Medical Center
      • Houston, Texas, United States, 77030
        • Baylor College of Medicine
      • Houston, Texas, United States, 77030
        • Texas Children's Hospital
      • Houston, Texas, United States, 77030
        • University of Texas Health Science Center at Houston
      • San Antonio, Texas, United States, 78229
        • University of Texas Health Science Center at San Antonio
      • San Antonio, Texas, United States, 78229
        • Methodist Healthcare System of San Antonio
    • Virginia
      • Falls Church, Virginia, United States, 22042
        • Inova Fairfax Hospital
      • Norfolk, Virginia, United States, 23507
        • Sentara Cardiovascular Research Institute
    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53215
        • Aurora Health Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

community centers, academic institutions

Description

Inclusion Criteria:

  • Clinical diagnosis of PAH, WHO GROUP I
  • Prescribed and is currently receiving Tyvaso and/or other FDA-approved therapy for the treatment of PAH
  • Willing and able to provide written informed consent

Exclusion Criteria:

  • Previous initiation and permanent discontinuation of Tyvaso
  • Participation in an investigational clinical drug or device trial within 30 days of enrollment
  • Current or past diagnosis of lung neoplasm
  • Active gastrointestinal or pulmonary bleed at enrollment
  • Planned surgical intervention for treatment of PAH e.g., atrial septostomy or transplant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Tyvaso
The Tyvaso group will consist of patients receiving Tyvaso and may be receiving another FDA approved PAH therapy as part of routine care.
Drug: inhaled prostacyclin
Tyvaso
Other Names:
  • treprostinil
Drug: inhaled prostacyclin
As prescribed by the physician
Other Names:
  • iloprost, Ventavis
Control
The control group will consist of patients with no previous Tyvaso exposure and not taking Tyvaso at the time of the Baseline visit, but receiving any other FDA approved PAH therapy as part of routine care.
Drug: inhaled prostacyclin
Tyvaso
Other Names:
  • treprostinil
Drug: inhaled prostacyclin
As prescribed by the physician
Other Names:
  • iloprost, Ventavis
Drug: prostacyclin
As prescribed by the physician
Other Names:
  • epoprostenol sodium, Flolan
Drug: subcutaneous and intravenous prostacyclin
As prescribed by physician
Other Names:
  • treprostinil , Remodulin
Drug: oral ERA
As prescribed by physician
Other Names:
  • bosentan, Tracleer
  • ambrisentan, Letairis
Drug: oral PDE5 inhibitors
As prescribed by physician
Other Names:
  • sildenafil, Revatio
  • tadalafil, Adcirca

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of Respiratory Tract-Related Adverse Events of Interest
Time Frame: Follow-up every 3 months
Percentage of patients who experienced a respiratory tract-related adverse event (grouped by category of interest) during the study.
Follow-up every 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

United Therapeutics

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

December 22, 2010

First Submitted That Met QC Criteria

December 23, 2010

First Posted (Estimate)

December 24, 2010

Study Record Updates

Last Update Posted (Estimate)

February 17, 2016

Last Update Submitted That Met QC Criteria

January 20, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RIN-PH-403

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Arterial Hypertension

Clinical Trials on inhaled prostacyclin

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe